Celcuity Inc. (CELC): Capital Expenditures
$249.0K
Year ended 2025-12-31
$450.0K
Trailing 12 months to 2026-06-30
+16.2%
3-year compound annual growth
+22.7%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $249.0K | -0.4% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $250.0K | +156.0% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $97.6K | -38.5% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $158.8K | +93.9% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $81.9K | -8.4% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $89.4K | n/c | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$380.2K | n/c | 2021-02-16, From 2019-01-01 |
| 2018-12-31 | $629.6K | +162.5% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $239.8K | +486.4% | 2019-03-01, From 2017-01-01 |
| 2016-12-31 | $40.9K | n/a | 2018-03-15, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | $249.0K | -0.4% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $8.88M | +64.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $4.50M | +181.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $726.0K | n/m |
Compare CELC, CSTL, BLLN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗